Histogen Price To Book vs. Market Capitalization

HSTO Stock  USD 0.02  0.01  25.65%   
Considering Histogen's profitability and operating efficiency indicators, Histogen may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Histogen's ability to earn profits and add value for shareholders. As of the 29th of November 2024, Sales General And Administrative To Revenue is likely to grow to 4.44, while Price To Sales Ratio is likely to drop 0.77. At this time, Histogen's Interest Income is very stable compared to the past year. Net Interest Income is expected to grow at the current pace this year, though Accumulated Other Comprehensive Income is likely to grow to (12.8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.90.87
Sufficiently Up
Slightly volatile
For Histogen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Histogen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Histogen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Histogen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Histogen over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.81)
Revenue Per Share
0.004
Return On Assets
(0.54)
Return On Equity
(1.20)
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Histogen Market Capitalization vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Histogen's current stock value. Our valuation model uses many indicators to compare Histogen value to that of its competitors to determine the firm's financial worth.
Histogen is rated below average in price to book category among its peers. It also is rated below average in market capitalization category among its peers creating about  5,441,720  of Market Capitalization per Price To Book. At this time, Histogen's Market Cap is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Histogen's earnings, one of the primary drivers of an investment's value.

Histogen Market Capitalization vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Histogen

P/B

 = 

MV Per Share

BV Per Share

 = 
0.02 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Histogen

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
85.44 K
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Histogen Market Capitalization vs Competition

Histogen is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 758.3 Million. Histogen adds roughly 85,435 in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Workforce  Valuation  Total debt  Revenue

Histogen Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Histogen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Histogen will eventually generate negative long term returns. The profitability progress is the general direction of Histogen's change in net profit over the period of time. It can combine multiple indicators of Histogen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-13.5 M-12.8 M
Operating Income-12.1 M-12.7 M
Income Before Tax-12.4 M-13 M
Total Other Income Expense Net(900.00)(945.00)
Net Loss-12.4 M-13 M
Income Tax Expense-187.4 K-178.1 K
Interest Income653.2 K685.9 K
Net Loss-12.8 M-13.4 M
Net Loss-12.4 M-13 M
Change To Netincome621 K590 K
Net Loss(2.98)(3.13)
Income Quality 0.82  0.66 
Net Income Per E B T 1.15  1.36 

Histogen Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Histogen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Histogen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Histogen's important profitability drivers and their relationship over time.

Use Histogen in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.

Histogen Pair Trading

Histogen Pair Trading Analysis

The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Histogen position

In addition to having Histogen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Developed Markets Basket ETFs Thematic Idea Now

Developed Markets Basket ETFs
Developed Markets Basket ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Developed Markets Basket ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Developed Markets Basket ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Histogen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Histogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Histogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Histogen Stock:
Check out Risk vs Return Analysis.
To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
To fully project Histogen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Histogen at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Histogen's income statement, its balance sheet, and the statement of cash flows.
Potential Histogen investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Histogen investors may work on each financial statement separately, they are all related. The changes in Histogen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Histogen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.